TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06989775: BoxX-NoAF Clinical Trial

Sponsor: AtriCure, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 960 pts

Competing Trials Overlap
14 Active Trials
Excess Burn Exposure
$1,560,400
Rescue Site Savings
+$1,029,200
Unlock Full NCT06989775 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06989775 Rescue Dossier →